Highbridge Capital Management LLC Jasper Therapeutics, Inc. Transaction History

Highbridge Capital Management LLC

  • $333 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.73 - $3.86 $1,281 - $2,860
-741 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$2.96 - $8.01 $2,193 - $5,935
741 New
741 $3,000

Others Institutions Holding JSPR

# of Institutions
1
Shares Held
5.63M
Call Options Held
0
Put Options Held
0
View Full List

About Jasper Therapeutics, Inc.

JSPR Quotes by TradingView
  • Ticker JSPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,073,300
  • Market Cap $806M
  • Description
  • Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...
More about JSPR
Track This Portfolio

Track Highbridge Capital Management LLC Portfolio

Follow Highbridge Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highbridge Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email